199 related articles for article (PubMed ID: 19841087)
1. Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).
Fogelstrand P; Féral CC; Zargham R; Ginsberg MH
J Exp Med; 2009 Oct; 206(11):2397-406. PubMed ID: 19841087
[TBL] [Abstract][Full Text] [Related]
2. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis.
Baumer Y; McCurdy S; Alcala M; Mehta N; Lee BH; Ginsberg MH; Boisvert WA
Atherosclerosis; 2017 Jan; 256():105-114. PubMed ID: 28012647
[TBL] [Abstract][Full Text] [Related]
3. SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.
Qi W; Li Q; Liew CW; Rask-Madsen C; Lockhart SM; Rasmussen LM; Xia Y; Wang X; Khamaisi M; Croce K; King GL
Diabetologia; 2017 Mar; 60(3):585-596. PubMed ID: 27933336
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of allograft inflammatory factor-1 expression reduces development of neointimal hyperplasia and p38 kinase activity.
Sommerville LJ; Xing C; Kelemen SE; Eguchi S; Autieri MV
Cardiovasc Res; 2009 Jan; 81(1):206-15. PubMed ID: 18779232
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
7. Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.
Tian Y; Sommerville LJ; Cuneo A; Kelemen SE; Autieri MV
Am J Pathol; 2008 Sep; 173(3):901-9. PubMed ID: 18669613
[TBL] [Abstract][Full Text] [Related]
8. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
Xue CD; Chen Y; Ren JL; Zhang LS; Liu X; Yu YR; Tang CS; Qi YF
Peptides; 2019 Nov; 121():170131. PubMed ID: 31408662
[TBL] [Abstract][Full Text] [Related]
9. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
10. TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy.
Ostriker AC; Xie Y; Chakraborty R; Sizer AJ; Bai Y; Ding M; Song WL; Huttner A; Hwa J; Martin KA
Circulation; 2021 Aug; 144(6):455-470. PubMed ID: 34111946
[TBL] [Abstract][Full Text] [Related]
11. CD98hc (SLC3A2) mediates integrin signaling.
Feral CC; Nishiya N; Fenczik CA; Stuhlmann H; Slepak M; Ginsberg MH
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):355-60. PubMed ID: 15625115
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
[TBL] [Abstract][Full Text] [Related]
13. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
14. Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice.
Sommerville LJ; Kelemen SE; Autieri MV
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):47-53. PubMed ID: 17991871
[TBL] [Abstract][Full Text] [Related]
15. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model.
Matsumae H; Yoshida Y; Ono K; Togi K; Inoue K; Furukawa Y; Nakashima Y; Kojima Y; Nobuyoshi M; Kita T; Tanaka M
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1077-83. PubMed ID: 18388330
[TBL] [Abstract][Full Text] [Related]
16. Prx1 promotes the proliferation and migration of vascular smooth muscle cells in a TLR4-dependent manner.
Zhu Z; Zheng X; Li D; Wang T; Xu R; Piao H; Liu K
Mol Med Rep; 2017 Jan; 15(1):345-351. PubMed ID: 27922677
[TBL] [Abstract][Full Text] [Related]
17. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
[TBL] [Abstract][Full Text] [Related]
18. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
[TBL] [Abstract][Full Text] [Related]
19. miR-145 inhibits the proliferation and migration of vascular smooth muscle cells by regulating autophagy.
Wang W; Chen L; Shang C; Jin Z; Yao F; Bai L; Wang R; Zhao S; Liu E
J Cell Mol Med; 2020 Jun; 24(12):6658-6669. PubMed ID: 32337837
[TBL] [Abstract][Full Text] [Related]
20. Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
Izumi Y; Kim S; Yoshiyama M; Izumiya Y; Yoshida K; Matsuzawa A; Koyama H; Nishizawa Y; Ichijo H; Yoshikawa J; Iwao H
Circulation; 2003 Dec; 108(22):2812-8. PubMed ID: 14638553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
